Ergebnis der Suchanfrage nach celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 3Ein Dokumentmehr
Medison Pharma; Alnylam Pharmaceuticals
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Zug, Switzerland (ots/PRNewswire) - - The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance - Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient ...
mehrAdvanced Brain Science Without Coding Expertise
mehrFraunhofer-Institut für Produktionstechnologie IPT
Hydrogen technologies at the Hannover Messe 2024: Fraunhofer IPT presents system designs for the production of bipolar plates, MEAs and pressure tanks
mehrCustomCells strengthens its commitment in eAviation
mehrNorgine B.V. submits Marketing Authorisation Application via Project Orbis for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Amsterdam (ots/PRNewswire) - Norgine B.V. today announced its first marketing authorisation application submissions on 10 April 2024, seeking approval for eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone supports Norgine's efforts to ...
mehrAsthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease
Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American Journal of Respiratory and ...
mehrTechnische Universität München
Boron deficiency: oilseed rape reacts as with infection and pest infestation | Genetic mechanisms uncovered
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Genetic mechanisms uncovered Boron deficiency: oilseed rape reacts as with infection and pest infestation - Oilseed rape reacts to boron deficiency during flowering in a similar way as to pests and infections - Boron deficiency could become an increasing problem due to ...
mehrYou are cordially invited to Festo's press meeting with C. Gerhardt at Analytica
mehrScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
mehrARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
mehr- 4
Technological milestone in the new food industry: GEA presents perfusion as key process at Anuga FoodTec
Ein Dokumentmehr Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with ...
mehrCustomCells founds U.S. subsidiary with Detroit site
mehrInvitation to press briefing at Anuga FoodTec 2024: Discover the Future of New Food Production
mehrInvitation to press briefing at Anuga FoodTec 2024: Discover the Future of New Food Production
mehr- 9
Football fans from Europe visit the champion of structural change in Gelsenkirchen
Ein Dokumentmehr Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrAston Martin Lagonda of Europe GmbH
10New Aston Martin Vantage GT4 completes top-flight line-up of production-based GT racers
mehr- 4
GEA at the Anuga FoodTec trade show: Sustainability innovations bolster food industry resilience
Ein Dokumentmehr Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
mehrWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
mehrHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
mehr- 3
GEA invests EUR 18 million in technology center for alternative proteins in the USA
Ein Dokumentmehr Aston Martin Lagonda of Europe GmbH
10STATE-OF-THE-ART ASTON MARTIN VANTAGE GT3 SPEARHEADS NEW ERA IN TOP-FLIGHT GT RACING
mehrPolaroid Therapeutics completes pre-clinical milestones in the development of superior antimicrobial technology for acute and chronic wounds
Bern, Switzerland (ots/PRNewswire) - - Its proprietary innovative polymer technology reduces bacterial bioburden without triggering antimicrobial resistance, one of the top global public health threats - The Advanced Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing increasing demand and ...
mehr- 2
PM: DHL Group mit Wasserstoff-LKWs im Rheinland unterwegs / PR: DHL Group deploying hydrogen trucks in Germany
2 Dokumentemehr Strengthening the Direct Sales and Service System for Business Expansion in Italy
Ein DokumentmehrBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehr